Judge Approves $150M Flonase Antitrust Accord

Law360, Miami (June 14, 2013, 6:57 PM EDT) -- A Pennsylvania federal judge on Friday approved a $150 million settlement, including $50 million in attorneys' fees, ending a direct purchaser antitrust class action accusing GlaxoSmithKline of filing sham petitions with federal authorities to delay generic alternatives to Flonase nasal spray.

U.S. Federal Judge Anita B. Brody signed off on the deal with the class of direct purchasers, led by Meijer Inc. and American Sales Co., that was hammered out in December. Indirect purchaser plaintiffs also have asked for approval of a $45 million class action...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.